Tested Applications
Positive WB detected in | A375 cells, U-87 MG cells, U-251 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
86298-2-RR targets IL-13RA2 in WB, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | IL-13RA2 fusion protein Eg2579 Predict reactive species |
Full Name | interleukin 13 receptor, alpha 2 |
Calculated Molecular Weight | 380 aa, 44 kDa |
Observed Molecular Weight | 60 kDa |
GenBank Accession Number | BC020739 |
Gene Symbol | IL13RA2 |
Gene ID (NCBI) | 3598 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | Q14627 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
IL-13RA2, also named as IL-13R and CD213a2, belongs to the type I cytokine receptor family. It binds as a monomer with high affinity to interleukin-13 (IL13), but not to interleukin-4 (IL4). IL-13RA2 lacks the cytoplasmic domain for signaling, indicating that it acts as a decoy receptor. IL-13RA2 gene polymorphisms have been associated with systemic sclerosis (PMID: 16981293). Overexpression of IL-13RA2 gene has been reported in several types of cancer, including melanoma, lung cancer, and brain tumor, which makes it a potential immunotherapeutic target (PMID: 19895199; 24970476; 24021875).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for IL-13RA2 antibody 86298-2-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |